Learn more about Peter Attia’s digital program
#216 – Metabolomics, NAD+, and cancer metabolism | Josh Rabinowitz, M.D., Ph.D.
“My big hope is that we’re going to be able to have some combination of directed, metabolic immune supplements and diet that really work with therapy to treat cancer.” —Josh Rabinowitz
A pilot immunotherapy trial is one step on a long road toward curing cancer
“Remission in every patient” reads the New York Times headline about a study published earlier this month in the New…
#202 – Peter on nutrition, disease prevention, sleep, and more — looking back on the last 100 episodes
“I really think that in 10 years we’re going to basically be using designer-based immunotherapies to eradicate most solid organ metastatic cancers.” —Peter Attia
#177 – Steven Rosenberg, M.D., Ph.D.: The development of cancer immunotherapy and its promise for treating advanced cancers
“It’s the balance of the aggressive immune reaction against the inhibitory molecules that can prevent that immune reaction that is the holy grail of trying to find effective treatments.” —Steven Rosenberg
#115 – David Watkins, Ph.D.: A masterclass in immunology, monoclonal antibodies, and vaccine strategies for COVID-19
“As we stand here with the coronavirus epidemic three months old, I think we should have faith that science will find a solution to this.” — David Watkins